Harrow Health, Inc. (HROW)
NASDAQ: HROW · IEX Real-Time Price · USD
24.44
+0.21 (0.87%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Harrow Health Market Cap
Harrow Health has a market cap or net worth of $864.73 million as of July 26, 2024. Its market cap has increased by 56.63% in one year.
Market Cap
864.73M
Enterprise Value
976.53M
1-Year Change
56.63%
Ranking
Category
Stock Price
$24.44
Market Cap Chart
Since March 31, 2009, Harrow Health's market cap has increased from $14.00M to $864.73M, an increase of 6,076.67%. That is a compound annual growth rate of 30.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2024 | 857.30M | 117.98% |
Dec 29, 2023 | 393.30M | -2.79% |
Dec 30, 2022 | 404.60M | 74.10% |
Dec 31, 2021 | 232.40M | 31.60% |
Dec 31, 2020 | 176.60M | -9.81% |
Dec 31, 2019 | 195.80M | 47.77% |
Dec 31, 2018 | 132.50M | 279.66% |
Dec 29, 2017 | 34.90M | 5.44% |
Dec 30, 2016 | 33.10M | -50.67% |
Dec 31, 2015 | 67.10M | -3.31% |
Dec 31, 2014 | 69.40M | 130.56% |
Dec 31, 2013 | 30.10M | -53.19% |
Dec 31, 2012 | 64.30M | 3,284.21% |
Dec 30, 2011 | 1.90M | -85.04% |
Dec 31, 2010 | 12.70M | -45.96% |
Dec 31, 2009 | 23.50M | 67.86% |
Mar 31, 2009 | 14.00M | - |
View and export this data all the way back to 2009.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
GeneDx Holdings | 884.95M |
Cogent Biosciences | 876.77M |
The Pennant Group | 870.73M |
Liquidia | 866.53M |
Perspective Therapeutics | 864.45M |
Mesoblast | 841.64M |
Standard BioTools | 833.45M |
Olema Pharmaceuticals | 828.94M |